Research programme: long acting beta 2 adrenoceptor agonists - AlmirallAlternative Names: LAS 186368
Latest Information Update: 16 Jul 2016
Price : $50
At a glance
- Originator Laboratorios Almirall
- Developer Almirall S.A.
- Mechanism of Action Beta 2 adrenergic receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Chronic obstructive pulmonary disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Asthma in Spain (Inhalation)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Chronic-obstructive-pulmonary-disease in Spain (Inhalation)
- 02 Aug 2007 Preclinical trials in Chronic obstructive pulmonary disease in Spain (Inhalation)